DE1431167U - - Google Patents

Info

Publication number
DE1431167U
DE1431167U DENDAT1431167D DE1431167DU DE1431167U DE 1431167 U DE1431167 U DE 1431167U DE NDAT1431167 D DENDAT1431167 D DE NDAT1431167D DE 1431167D U DE1431167D U DE 1431167DU DE 1431167 U DE1431167 U DE 1431167U
Authority
DE
Germany
Prior art keywords
koa
üed
ïob
ättiguttbus
zzied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1431167D
Other languages
German (de)
English (en)
Publication of DE1431167U publication Critical patent/DE1431167U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1431167D Active DE1431167U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1431167U true DE1431167U (enrdf_load_stackoverflow)

Family

ID=740266

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1431167D Active DE1431167U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1431167U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
ES2236775T3 (es) Formulacion de liberacion sostenida que contiene colageno y glocosaminoglucano.
Andersson et al. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues
AU777300B2 (en) Methods for treating congestive heart failure
Thorne et al. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations
US8916616B2 (en) Multi-functional polymeric materials and their uses
Krewson et al. Distribution of nerve growth factor following direct delivery to brain interstitium
CA2184242C (en) Drug targeting system, method for preparing same and its use
DE69428992T2 (de) Immunologische verbesserung mit intermittierender interleukin-2 therapie
US20110177027A1 (en) COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
DE1431167U (enrdf_load_stackoverflow)
DE1213032T1 (de) Behandlung von Krankheiten durch ortsspezifische Instillation von Zellen oder ortsspezifischer Transformation von Zellen sowie Ausrüstung dafür
Rezazadeh et al. A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies
US11723956B2 (en) Immunomodulation after locoregional anti-tumoral treatment
US20250058017A1 (en) Extracellular matrix-based hybrid ink for 3d printing and method for manufacturing the same
KR20040052510A (ko) 림포카인 제조 및 증식성 세포 질환의 국소 조절 또는국소와 전신 조절을 위한 이의 용도
CN116867509A (zh) 用于葡萄糖响应性胰岛素递送的可注射可生物降解的聚合物复合物
Reddan et al. Aqueous humor from traumatized eyes triggers cell division in the epithelia of cultured lenses
WO2009012443A1 (en) Nanoparticles for the elution of growth factors for recovery and regeneration of organs
WO2020194034A1 (en) Nanoparticle of chitosan and cyclodextrin containing encapsulated interferon and pharmaceutical compositions that contain it
Maeda et al. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor‐α and‐β: an in vitro and in vivo study
KR20140015264A (ko) 서방성 의약 조성물
Quinton et al. Use of colony-stimulating factors for treatment of neutropenia and infectious diseases
Narayanaswamy et al. Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women
Bobak Effects of perioperative human granulocyte colony-stimulating factor on immune function and perioperative infections in patients undergoing abdominal surgery
Choe et al. Spectral and fluorescence imaging of immune system and tissue response to an immunogenic agent